Natural Killer Cells and Bortezomib to Treat Cancer

NCT00720785 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Chronic Myeloid Leukemia (CML)
Pancreatic Ca
Colon/Rectal Ca
Multiple Myeloma
Carcinoma, Non-Small -Cell Lung

Interventions

DRUG: Bortezomib
BIOLOGICAL: NK cells

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)